Pharma Focus Europe

Cellipont Bioservices Announces Opening of New Facility for Manufacturing Cell Therapies

Friday, March 08, 2024

Cellipont Bioservices is excited to announce the opening of its advanced 76,000 sq. ft. manufacturing facility in The Woodlands, TX. The facility features 7 clean rooms, QC labs, temperature-controlled storage, segregated shipping bays, warehouse space, and administrative offices, marking a significant step in Cellipont's mission to advance cell therapy development and manufacturing for the benefit of patients worldwide.

Darren Head, Executive Chairman of the Board for Cellipont, expressed enthusiasm for the facility's opening, stating, "Equipped with the latest technology and designed to meet the highest quality standards, this facility demonstrates our commitment to advancing cell therapy manufacturing and, most importantly, to helping patients in need."

Michael O'Mara, Chief Operating Officer of Cellipont, highlighted the company's strategic approach during the facility's design phase, stating, "During the design phase in early 2022, Cellipont made a strategic decision to not only meet current regulatory standards but also anticipate future ones. In the dynamic landscape of cell therapy, we aimed to remain at the forefront."

Ann Tanabe, CEO of BioHouston, commended Cellipont's dedication to advancing cell therapy manufacturing, stating, "Cellipont's commitment to excellence is commendable. Their new facility sets a remarkable standard for quality and efficiency in the industry, and we're excited to have this valuable resource in the Houston region."

 

Source: prnewswire.com

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva